F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its half year results 2022 (January 1 - June 30, 2022).
Roche owns 59.89% of Chugai's outstanding shares (61.14% of voting rights) as of the end of June 2022.
Its investor update and presentation materials can be found on its website (https://www.roche.com/).
Chugai's performance for the period of January 1 to June 30, 2022 is included in the announced Roche Group's results.
Contact:
Media
Chugai Pharmaceutical Co., Ltd.
Media Relations Group
Corporate Communications Dept.
Tomoko Shimizu
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp
(C) 2022 Electronic News Publishing, source ENP Newswire